Varvel Stephen A, Wise Laura E, Niyuhire Floride, Cravatt Benjamin F, Lichtman Aron H
Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA 23298-0613, USA.
Neuropsychopharmacology. 2007 May;32(5):1032-41. doi: 10.1038/sj.npp.1301224. Epub 2006 Oct 18.
Recent reports have demonstrated that disruption of CB(1) receptor signaling impairs extinction of learned responses in conditioned fear and Morris water maze paradigms. Here, we test the hypothesis that elevating brain levels of the endogenous cannabinoid anandamide through either genetic deletion or pharmacological inhibition of its primary catabolic enzyme fatty-acid amide hydrolase (FAAH) will potentiate extinction in a fixed platform water maze task. FAAH (-/-) mice and mice treated with the FAAH inhibitor OL-135, did not display any memory impairment or motor disruption, but did exhibit a significant increase in the rate of extinction. Unexpectedly, FAAH-compromised mice also exhibited a significant increase in acquisition rate. The CB(1) receptor antagonist SR141716 (rimonabant) when given alone had no effects on acquisition, but disrupted extinction. Additionally, SR141716 blocked the effects of OL-135 on both acquisition and extinction. Collectively, these results indicate that endogenous anandamide plays a facilitatory role in extinction through a CB(1) receptor mechanism of action. In contrast, the primary psychoactive constituent of marijuana, Delta(9)-tetrahydrocannabinol, failed to affect extinction rates, suggesting that FAAH is a more effective target than a direct acting CB(1) receptor agonist in facilitating extinction. More generally, these findings suggest that FAAH inhibition represents a promising pharmacological approach to treat psychopathologies hallmarked by an inability to extinguish maladaptive behaviors, such as post-traumatic stress syndrome and obsessive-compulsive disorder.
最近的报告表明,在条件性恐惧和莫里斯水迷宫实验范式中,CB(1)受体信号的破坏会损害习得反应的消退。在此,我们检验以下假设:通过基因敲除或对其主要分解代谢酶脂肪酸酰胺水解酶(FAAH)进行药理学抑制来提高内源性大麻素花生四烯乙醇胺的脑内水平,将增强固定平台水迷宫任务中的消退。FAAH基因敲除小鼠和用FAAH抑制剂OL-135处理的小鼠,未表现出任何记忆损害或运动障碍,但确实表现出消退速率显著增加。出乎意料的是,FAAH功能受损的小鼠在习得速率上也显著增加。CB(1)受体拮抗剂SR141716(利莫那班)单独给药时对习得无影响,但会破坏消退。此外,SR141716阻断了OL-135对习得和消退的影响。总体而言,这些结果表明内源性花生四烯乙醇胺通过CB(1)受体作用机制在消退中起促进作用。相比之下,大麻的主要精神活性成分Δ9-四氢大麻酚未能影响消退速率,这表明在促进消退方面,FAAH是比直接作用的CB(1)受体激动剂更有效的靶点。更普遍地说,这些发现表明,FAAH抑制代表了一种有前景的药理学方法,可用于治疗以无法消除适应不良行为为特征的精神病理学疾病,如创伤后应激障碍和强迫症。